Behandlingen skall avbrytas omedelbart om neurotoxicitet grad 3 eller 4 observeras. ###>Treatment with ALIMTA should be discontinued if a patient experiences any haematologic or non-haematologic Grade 3 or 4 toxicity after 2 doses reductions or immediately if Grade 3 or 4 neurotoxicity is observed.